University of Guelph researchers are the first to uncover how the cannabis plant creates important pain-relieving molecules that are 30 times more powerful at reducing inflammation than Aspirin.
The discovery unlocks the potential to create a naturally derived pain treatment that would offer potent relief without the risk of addiction of other painkillers.
These molecules are non-psychoactive and they target the inflammation at the source, making them ideal painkillers.
Biosynthesis of cannflavins A and B from Cannabis sativa L.
Wyniki badania w skrócie:
- Cannflavin A and B are prenylated flavonoids that are unique to Cannabis sativa.
- Cannflavins exhibit anti-inflammatory activity that is thirty times that of aspirin.
- Cannflavins are synthesized via a branch point from the phenylpropanoid pathway.
- A single prenyltransferase converts chrysoeriol to cannflavin A and B.
